Maraviroc, a chemokine receptor-5 antagonist, fails to...

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona L Fleishaker, Juan A Garcia Meijide, Andriy Petrov…
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
DOI:
10.1186/ar3685
Date:
February, 2012
File:
PDF, 587 KB
english, 2012
Conversion to is in progress
Conversion to is failed